Balance Sheet
Accumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesPayablesPreferred Stock LiabilitiesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GP-Act III Acquisition (GPAT) Liabilities and Shareholders Equity (2023 - 2025)

GP-Act III Acquisition (GPAT) has disclosed Liabilities and Shareholders Equity for 3 consecutive years, with $309.4 million as the latest value for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity rose 4.0% to $309.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.2 billion through Dec 2025, up 38.09% year-over-year, with the annual reading at $309.4 million for FY2025, 4.0% up from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $309.4 million at GP-Act III Acquisition, up from $306.5 million in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $309.4 million in Q4 2025, with the low at $530238.0 in Q4 2023.
  • Average Liabilities and Shareholders Equity over 3 years is $233.7 million, with a median of $297.5 million recorded in 2024.
  • The sharpest move saw Liabilities and Shareholders Equity soared 56001.91% in 2024, then increased 4.0% in 2025.
  • GP-Act III Acquisition's Liabilities and Shareholders Equity stood at $530238.0 in 2023, then soared by 56001.91% to $297.5 million in 2024, then grew by 4.0% to $309.4 million in 2025.
  • Per Business Quant, the three most recent readings for GPAT's Liabilities and Shareholders Equity are $309.4 million (Q4 2025), $306.5 million (Q3 2025), and $303.4 million (Q2 2025).